Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease".
Saved in:
| Title: | Reply to: "Overlapping Ranges in Levels Indicate That Hexosylsphingosine Is Not a Clinically Relevant Biomarker for GBA1-Associated Parkinson's Disease". |
|---|---|
| Authors: | Gleason AM; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Tayebi N; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Lopez GJ; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA., Sidransky E; Medical Genetics Branch, National Institutes of Health, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA. |
| Source: | Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2022 Aug; Vol. 37 (8), pp. 1781-1782. |
| Publication Type: | Letter; Research Support, N.I.H., Intramural; Comment |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
